Private Wealth Management Group, LLC Vaxcyte, Inc. Transaction History
Private Wealth Management Group, LLC
- $271 Billion
- Q1 2025
A detailed history of Private Wealth Management Group, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 36 shares of PCVX stock, worth $1,169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36
Previous 43
16.28%
Holding current value
$1,169
Previous $3.52 Million
61.36%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PCVX
# of Institutions
345Shares Held
136MCall Options Held
348KPut Options Held
250K-
Ra Capital Management, L.P. Boston, MA12.2MShares$396 Million9.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$391 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.8MShares$382 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$323 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA6.42MShares$208 Million0.05% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $1.93B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...